Sector ratings Bayer AG

Equities

Market Closed - Xetra Other stock markets 01:45:24 06/12/2025 am IST			5-day change	1st Jan Change
33.40 ^EUR	-0.68%		+9.06%	+72.91%

04/12	Evotec's Partner Bayer Starts Mid-stage Study of Genetic Kidney Disease Drug	MT
04/12	Bayer Starts Phase IIa Study for Treatment of Patients with Alport Syndrome	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
BAYER AG	3.85TCr		AA
ELI LILLY AND COMPANY	91TCr		A
JOHNSON & JOHNSON	49TCr		BBB
ABBVIE INC.	40TCr		AA
ROCHE HOLDING AG	33TCr		AA
ASTRAZENECA PLC	28TCr		A
NOVARTIS AG	26TCr		AAA
MERCK & CO., INC.	25TCr		A
NOVO NORDISK A/S	21TCr		A
AMGEN INC.	18TCr		A
GILEAD SCIENCES, INC.	15TCr		AAA
PFIZER INC.	15TCr		BBB
SANOFI	12TCr		A
VERTEX PHARMACEUTICALS INCORPORATED	12TCr		AA
BRISTOL-MYERS SQUIBB COMPANY	11TCr		A
GSK PLC	9.79TCr		AA
CHUGAI PHARMACEUTICAL CO., LTD.	9.01TCr		AA
ALLERGAN PLC	6.37TCr	-	-	-	-	-	-	-
ALNYLAM PHARMACEUTICALS, INC.	6.15TCr		AA	-
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	5.76TCr		AA
Average	21.81TCr		AA
Weighted average by Cap.			AA